David Adlington

Falko Friedrichs

Graham Doyle

Hugo Solvet

James Vane-Tempest

Hassan Al-Wakeel

Marianne Bulot

Oliver Metzger

Richard Felton

Robert Davies

Veronika Dubajova

Victoria Lambert

Giang Nguyen

Lisa Clive

- Fresenius Medical Care (FME) **invested EUR 312 million** to increase its ownership stake in Interwell Health (IWH), accelerating the timeline originally set for this transaction.  **[1333141_0001104659-25-091447_tm2526545d1_ex99-1.htm:0]** **[1333141_0001104659-25-091447_tm2526545d1_ex99-1.htm:1]** 
- **Tommy P. O’Connor** has been appointed as the new CEO of Interwell Health and business segment leader of Value-Based Care, effective **October 1, 2025**, succeeding Robert Sepucha.  **[1333141_0001104659-25-091447_tm2526545d1_ex99-1.htm:0]** **[1333141_0001104659-25-091447_tm2526545d1_ex99-1.htm:1]** 
- Interwell Health (IWH) generated **EUR 1,035 million in revenue** for the first six months of the year and experienced **23.5% revenue growth** during this period.  **[1333141_0001104659-25-091447_tm2526545d1_ex99-1.htm:1]**

Fresenius Medical Care Increases Interwell Health Ownership and Appoints New CEO

- Fresenius Medical Care (FME) invested **EUR 312 million** to increase its ownership stake in Interwell Health (IWH), accelerating the timeline originally set during the August 2022 merger of Cricket Health, IWH, and Fresenius Health Partners.  **[1333141_20250918NE77371:0]** 
- **Tommy P. O'Connor** has been appointed CEO of Interwell Health and Operating Segment leader of Value-Based Care, effective **October 1, 2025**, succeeding Robert Sepucha.  **[1333141_20250918NE77371:0]** 
- Interwell Health generated **EUR 1,035 million** in revenue for the first six months of the year, experiencing **23.5%** revenue growth during this period.  **[1333141_20250918NE77371:0]**

Fresenius Medical Care (FMS)